|
Health Action International HAI |
|
|
Contributions |
|
Article from mms-bulletin:
Bulletin No. 68, March 1998
"Suitable for migraine, kidney stones, sexual stress, frost-bite..."
Herbal Remedies: Consumer Protection Concerns
(E
|
Malaysia
|
Health Action International HAI)
Kumariah Balasubramaniam
| There are more effective, safe and good quality modern pharmaceuticals available today than ever before. However, it is paradoxical that consumers, particularly in the developed countries, are purchasing and using more and more herbal remedies. There is evidence that some of the herbal remedies in the market are not safe, effective and of good quality. This raises the issue of consumer safety.
Bulletin No. 68, March 1998
Power, Patents and Pills
Globalisierung, Neue Welthandelsordnung, internationale Patentbestimmungen und die Konsequenzen für die Versorgung der Dritten Welt mit Arzneimitteln
(E
|
Health Action International HAI)
Unter dem Titel „Power, Patents and Pills“ liegt jetzt ein Bericht zu den Folgen der Freihandels-Vereinbarung GATT und der Schaffung der Welthandelsorganisation WTO für die Versorgung der Dritten Welt mit Arzneimitteln vor.
Bulletin No. 68, March 1998
Une invitation à suivre les règles...
"Les échanges de médicaments entre les pays européens et les pays en développement"
(F
|
Health Action International HAI)
Bas van der Heide
| Une brochure récemment publiée fait le point sur l'état actuel et l'efficacité de la régulation de l'exportation de médicaments dans 17 pays européens (dont la Suisse) et met en évidence les principaux problèmes. Le document couvre également les aspects réglementaires du marché pharmaceutique de 17 pays en développement.
Med in Switzerland:
(D)
Thomas Schwarz, Jörg Schaaber
|
Die Freihandels-Vereinbarung GATT und die Schaffung der Welthandelsorganisation WTO haben für die Versorgung der Dritten Welt mit Arzneimitteln weitreichende Konsequenzen. Erstmals werden die Länder gezwungen, Patente für Arzneimittel zu akzeptieren. "Kopf - Transnationale Firmen gewinnen, Zahl - Entwicklungsländer verlieren". Mit dieser moderne Variante eines Kinderspiels verdeutlicht Kumariah Balasubramaniam, Asien-Koordinator von Health Action International (HAI), seine Einschätzung, dass die neuen Welthandelsvereinbarungen so gestaltet sind, dass sie den grossen Firmen ein Maximum an Freiheit in ihren Entscheidungen und den nationalen Regierungen ein Minimum an Einfluss auf die Wirtschaft zugestehen.
News:
()
HAI
|
"This years’ World Health Assembly (WHA) was historic. Health Action International (HAI) followed some of the most controversial issues that were up for discussion on this ambitious agenda: the debates and action around agenda items 11.3 Global Strategy and Plan of Action (GSPA) on Public Health Innovation and Intellectual Property, and 11.20 Counterfeit Medical Products. On both issues, the debate ... 
(E)
HAI, WHO
|
In May 2008 Health Action International (HAI) and the World Health Organization (Department of Medicine Policy and Standards) published the 2nd edition of a manual to collect and analyse medicine prices (patient prices and government procurement prices) across sectors and regions in a country, as well as medicine availability, treatment affordability and all price components in the supply chain from ...
(E)
HAI, WHO
|
In May 2008 Health Action International (HAI) and the World Health Organization (Department of Medicine Policy and Standards) published the 2nd edition of a manual to collect and analyse medicine prices (patient prices and government procurement prices) across sectors and regions in a country, as well as medicine availability, treatment affordability and all price components in the supply chain from ...
Why isn’t the world’s public health body – WHO – a proposed stakeholder in the development of the R&D treaty?
Presse Release of Health Action International
(E)
HAI
|
"The United States and the European Union are again impeding
multilateralism on the Essential Health and Biomedical Research & Development(R&D) Treaty at the World Health Assembly (WHA) this week. Such a Treaty has the potential to make a groundbreaking contribution to sustainable R&D for innovative medicines to meet real health needs in developing countries."
Presse Release of Health Action International
Why isn’t the world’s public health body – WHO – a proposed stakeholder in the development of the R&D treaty?
Presse Release of Health Action International
(E)
HAI
|
"The United States and the European Union are again impeding
multilateralism on the Essential Health and Biomedical Research & Development(R&D) Treaty at the World Health Assembly (WHA) this week. Such a Treaty has the potential to make a groundbreaking contribution to sustainable R&D for innovative medicines to meet real health needs in developing countries."
Presse Release of Health Action International